Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Stopped The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.

Conditions

• Glioblastoma

Interventions

• RADIATION: Stereotactic Radiosurgery
• DRUG: Nivolumab
• DRUG: Valproate

Sponsor

University of Virginia